Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
- PMID: 37068602
- DOI: 10.1016/j.metabol.2023.155560
Response to letter by Muralidhar and Madhivanan: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
Epidemiology of sarcopenia: Prevalence, risk factors, and consequences.Metabolism. 2023 Jul;144:155533. doi: 10.1016/j.metabol.2023.155533. Epub 2023 Mar 11. Metabolism. 2023. PMID: 36907247
-
Letter to the Editor: Clarity and quality assessment of epidemiology of sarcopenia: Prevalence, risk factors, and consequences.Metabolism. 2023 Jul;144:155561. doi: 10.1016/j.metabol.2023.155561. Epub 2023 Apr 17. Metabolism. 2023. PMID: 37075859 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
